BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 6204001)

  • 1. Surface antigens of melanoma and melanocytes. Specificity of induction of Ia antigens by human gamma-interferon.
    Houghton AN; Thomson TM; Gross D; Oettgen HF; Old LJ
    J Exp Med; 1984 Jul; 160(1):255-69. PubMed ID: 6204001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential modulation by tumor necrosis factor and immune interferon of HLA class-II antigens expressed by melanoma cells.
    Maio M; Gulwani B; Morgano A; Ferrone S
    Int J Cancer; 1989 Sep; 44(3):554-9. PubMed ID: 2506138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
    Shaw AR; Chan JK; Reid S; Seehafer J
    J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant interferon-gamma can induce the expression of HLA-DR and -DC on DR-negative melanoma cells and enhance the expression of HLA-ABC and tumor-associated antigens.
    Carrel S; Schmidt-Kessen A; Giuffrè L
    Eur J Immunol; 1985 Feb; 15(2):118-23. PubMed ID: 3918869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of recombinant human leukocyte, fibroblast, and immune interferons on expression of class I and II major histocompatibility complex and invariant chain in early passage human melanoma cells.
    Nisticò P; Tecce R; Giacomini P; Cavallari A; D'Agnano I; Fisher PB; Natali PG
    Cancer Res; 1990 Dec; 50(23):7422-9. PubMed ID: 1701342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the antigenic phenotype of human melanoma cells by differentiation-inducing and growth-suppressing agents.
    Guarini L; Graham GM; Jiang H; Ferrone S; Zucker S; Fisher PB
    Pigment Cell Res; 1992; Suppl 2():123-31. PubMed ID: 1357650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of constitutive and IFN-gamma inducible expression of HLA class II molecules in human melanoma cell lines.
    Rodríguez T; Méndez R; Del Campo A; Aptsiauri N; Martín J; Orozco G; Pawelec G; Schadendorf D; Ruiz-Cabello F; Garrido F
    Immunogenetics; 2007 Feb; 59(2):123-33. PubMed ID: 17180681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical and functional analysis of HLA class II antigens induced by recombinant immune interferon on normal epidermal melanocytes.
    Tsujisaki M; Igarashi M; Sakaguchi K; Eisinger M; Herlyn M; Ferrone S
    J Immunol; 1987 Feb; 138(4):1310-6. PubMed ID: 3100635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of class I major histocompatibility complex antigens in human teratocarcinoma cells by interferon without induction of differentiation, growth inhibition, or resistance to viral infection.
    Andrews PW; Trinchieri G; Perussia B; Baglioni C
    Cancer Res; 1987 Feb; 47(3):740-6. PubMed ID: 3026615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of HLA-DR gene expression induced by IFN-gamma in malignant melanoma cell lines.
    Lee JL; Kim YH; Lee JM; Kim JD; Kim SJ; Park JH
    Yonsei Med J; 1999 Feb; 40(1):30-9. PubMed ID: 10198604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential.
    Maio M; Gulwani B; Langer JA; Kerbel RS; Duigou GJ; Fisher PB; Ferrone S
    Cancer Res; 1989 Jun; 49(11):2980-7. PubMed ID: 2497970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of HLA molecules and stimulation of autologous human tumor infiltrating lymphocytes following transduction of melanoma cells with gamma-interferon genes.
    Ogasawara M; Rosenberg SA
    Cancer Res; 1993 Aug; 53(15):3561-8. PubMed ID: 8101762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of Ia by murine keratinocytes and gut epithelium in response to recombinant gamma-interferon.
    Jun BD; Krueger GG; Roberts LK
    J Invest Dermatol; 1989 Jul; 93(1):33-9. PubMed ID: 2473137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant interferon-gamma increases HLA-DR synthesis and expression.
    Basham TY; Merigan TC
    J Immunol; 1983 Apr; 130(4):1492-4. PubMed ID: 6403609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human interferon-gamma induces expression of HLA-DR on keratinocytes and melanocytes.
    Auböck J; Niederwieser D; Romani N; Fritsch P; Huber C
    Arch Dermatol Res; 1985; 277(4):270-5. PubMed ID: 3923947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discoordinate surface expression of IFN-gamma-induced HLA class II proteins in nonprofessional antigen-presenting cells with absence of DM and class II colocalization.
    Muczynski KA; Anderson SK; Pious D
    J Immunol; 1998 Apr; 160(7):3207-16. PubMed ID: 9531276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
    Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
    Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IFN-gamma-regulated expression of a differentiation antigen of human cells.
    Real FX; Carrato A; Schuessler MH; Welt S; Oettgen HF
    J Immunol; 1988 Mar; 140(5):1571-6. PubMed ID: 3126230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo induction of Ia antigens on rat keratinocytes by gamma-interferon.
    Scheynius A; Johansson C; van der Meide PH
    Br J Dermatol; 1986 Nov; 115(5):543-9. PubMed ID: 2431705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.